Humanin Research & Listing Availability

Current Humanin vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.

Current Humanin vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.

About Humanin

Pre-clinical / research-onlyAlso known as: HN · MT-RNR2

Humanin is a 24-residue mitochondrial-derived peptide studied for cytoprotection and metabolic-aging research. It ships as a lyophilized powder you reconstitute before use, so vendor quality comes down to what the certificate of analysis (COA) shows.

What to check before you buy Humanin:

  • A third-party COA showing ≥98% purity by HPLC plus mass-spec confirmation of the 24-residue sequence.
  • A COA dated within the last 6–12 months matching the exact vial size and batch you are buying.
  • Accurate vial fill matching the labeled amount. Under-filled or mislabeled vials are a common failure mode and throw off your dose math.

Hashimoto 2001 established the anti-Alzheimer-β-toxicity signal that named the peptide.[1] Muzumdar 2009 showed humanin and its analogue HNG improve insulin sensitivity in rodents.[4] Lee 2015 (Cohen group) reported that circulating humanin levels decline with age in humans and rhesus macaques, and that low levels correlate with cognitive decline and metabolic disease risk.[2] No registered human clinical trial of humanin or its analogues has reported efficacy data to date.[5]

Regulatory: Not FDA-approved. No completed human clinical trial. Pre-clinical rodent and primate data plus human observational biomarker work only. Research-grade material for non-clinical use.

Read the full mechanism & research breakdown

Humanin: Mechanisms, Half-Life & Research Data

A skimmable deep dive into how Humanin works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.

How it works

Humanin is one of the small handful of peptides encoded inside the mitochondrial genome (its open reading frame sits within the 16S rRNA gene MT-RNR2), and it sits alongside MOTS-c and the SHLP family in the mitochondrial-derived peptide (MDP) class — see the standalone MOTS-c deep dive for class context.[2][6] Functionally, humanin operates through two distinct signalling arms. Intracellularly, it binds pro-apoptotic Bcl-2 family proteins (notably Bax) and blocks their oligomerisation at the outer mitochondrial membrane, preventing the pore formation and cytochrome-c release that initiate the intrinsic apoptosis cascade — the mechanism behind its rescue of Alzheimer's amyloid-β toxicity in the original Hashimoto screen.[1][3] Extracellularly, secreted humanin binds a heterotrimeric cell-surface receptor (CNTFR/WSX-1/gp130), activating STAT3 to produce cytoprotective and anti-inflammatory effects in distant tissues, with higher concentrations also engaging FPR2/ALX.[3] Circulating humanin levels fall with age in humans and primates, and low levels associate with worse cognitive and metabolic outcomes — the basis for the "MDP signalling network" framing that the Cohen lab and others have built around the class.[2][6][7]

Active research areas

  • Alzheimer's disease and neuroprotection (pre-clinical)
    The founding research area: humanin and the more potent analogue HNG (S14G-humanin) rescue cultured neurons from amyloid-β toxicity and reduce cognitive and pathological deficits in rodent Alzheimer's models.[1][3] No human Alzheimer's trial has been conducted.
  • Insulin sensitivity and metabolic regulation (pre-clinical + biomarker)
    Muzumdar 2009 showed that humanin and HNG improve insulin sensitivity in rodents, and human observational data link low circulating humanin to insulin resistance and type 2 diabetes risk.[4][7]
  • Healthspan and ageing biomarker (observational)
    Circulating humanin declines with age in humans and rhesus macaques, and centenarians and their offspring carry higher levels — supporting the framing of humanin as an "ageing biomarker," though causality has not been established.[2][6]
  • Cardioprotection and stroke (pre-clinical)
    HNG reduces infarct size in rodent models of myocardial ischemia–reperfusion injury and cerebral ischemia, consistent with the anti-apoptotic Bax-binding mechanism.[3][6] All work is pre-clinical.
  • No human clinical program
    There is no registered ClinicalTrials.gov efficacy trial of humanin or any humanin analogue.[5] All consumer use is occurring outside any clinical-trial framework on the basis of rodent data and human observational biomarker correlations.
Open questions & leading hypotheses (1)
  • Hypothesis: Restoring circulating humanin in older adults (via exogenous administration) would reproduce the cognitive, metabolic, and cardiovascular protection seen in animal models.
    Evidence: Rodent and primate pre-clinical work is consistent across multiple labs and the age-dependent decline in human humanin is well-documented.[1][2][3][4][6] Counter-evidence: humanin's extracellular receptor complex (CNTFR/WSX-1/gp130) signals through STAT3, which has both pro- and anti-tumour effects depending on tissue context; the pharmacokinetics, optimal route, and safe chronic-administration profile in humans are entirely uncharacterised; the same observational data that suggest a protective role could reflect reverse causation, where healthier mitochondria produce more humanin rather than humanin causing the health outcome.
What community users report

Anecdotal — not controlled-trial evidence

On r/Peptides and r/longevity, humanin is discussed primarily as a research-grade "mitochondrial peptide" alongside MOTS-c, with typical subcutaneous protocols of 1–5 mg several times per week.[8] Users report subjective improvements in energy and recovery, but the discussion volume is far smaller than for MOTS-c. **All reports are anecdotal, no human efficacy or safety data have been published, the consumer-dose schedule is extrapolated from rodent studies, and humanin is not FDA-approved for any indication.[5]**

Sources & references (8)

Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.

  1. [1]Hashimoto Y et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. PNAS 2001;98:6336–6341. · PMID: 11371646 link
  2. [2]Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab 2015;21:443–454 — Cohen-group review framing humanin within the mitochondrial-derived peptide class. · PMID: 25738459 link
  3. [3]Guo B et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003;423:456–461. · PMID: 12732850 link
  4. [4]Muzumdar RH et al. Humanin: a novel central regulator of peripheral insulin action. PLoS One 2009;4:e6334. · PMID: 19623253 link
  5. [5]ClinicalTrials.gov search "humanin", accessed May 2026 — no completed efficacy trial of humanin or HNG. link
  6. [6]Yen K et al. The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan. Aging (Albany NY) 2020;12:11185–11199. · PMID: 32575074 link
  7. [7]Cobb LJ et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY) 2016;8:796–809. · PMID: 27070352 link
  8. [8]Community report — r/Peptides and r/longevity humanin discussion threads (subreddits), accessed May 2026. link

Humanin Calculator Input Observations

In lifetime Humanin calculator inputs, 1mg is the most frequent entered amount (30 of 84 runs). Separately, Weekly (1x/wk) is the most frequent overall cadence (7 of 31 lifetime frequency responses, across entered amounts). Among lifetime frequency responses with amounts within ±8% of 1mg, Weekly (1x/wk) is most frequent (3 of 12 responses). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length.

About Humanin

Humanin is a 24-residue mitochondrial-derived peptide studied for cytoprotection and metabolic-aging research. It ships as a lyophilized powder you reconstitute before use, so vendor quality comes down to what the certificate of analysis (COA) shows.

Humanin is tracked under the Anti-Aging Peptides category on WPA. Its reported half-life is ~1 hour. Calculator inputs do not establish why a cadence was selected or validate a protocol. Not FDA-approved.

Frequently Asked Questions: Humanin

Are current Humanin offers available?

Current Humanin vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.

What can I check if Humanin listings become available?

Check the exact compound, format, labelled quantity, named laboratory, test date, and batch match. Confirm any future listing price, discount terms, and stock directly with the vendor. Catalog COA fields alone are not independent verification.

Does research activity establish current Humanin availability?

No. Search interest, calculator entries, historical prices, related compounds, and other formats do not establish current offers in this comparison. Research information and navigation to other compounds remain available.